Canopy Growth Corporation and AusCann Group Holdings

SMITHS FALLS, ON, May 20, 2016 /CNW/ - Canopy Growth Corporation ("Canopy Growth") recently issued a press release outlining a partnership with AusCann Group Holdings Ltd. ("AusCann"), whereby Canopy Growth would obtain certain equity holdings in AusCann, in exchange for its consultation in a number of areas including production, quality assurance and operations, and strategic advisory services.

Canopy Growth would like to clarify that all such expertise and advisory services offered or performed by Canopy Growth subsidiaries will be exclusively carried out by Tweed Inc. and Tweed Farms Inc. Procedures, expertise, and/or intellectual property under license from Bedrocan BV as to medicinal cannabis (flos) and so employed by Bedrocan Canada or any affiliates of Canopy Growth will not be shared or form the basis for any cooperation, consultation or other form of consulting provided under the terms of the partnership with AusCann. Canopy Growth and its affiliates are exclusively entitled to utilize any of its rights under the Bedrocan BV license for Canada and South-America only.

Here's to future (clarified) growth.

About Canopy Growth Corporation
Canopy Growth is Canada's first publicly traded medical marijuana company and the first geographically diversified producer with multiple licenses under the Marihuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed, Tweed Farms, and Bedrocan Canada, the Company operates three state-of-the-art production facilities in Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions. The Company is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, conducting robust clinical research, and furthering the public's understanding of how marijuana is used for medical purposes. www.canopygrowth.com

SOURCE Canopy Growth Corporation

Jordan Sinclair, Communications Manager, [email protected], 613-769-4196; Investor Contact: Tyler Burns, [email protected], 855-558-9333 ex 122; Director: Bruce Linton, Chairman and CEO, [email protected], 855-558-9333